Effects of nifedipine on systemic and pulmonary vascular impedance in subjects undergoing cardiac catheterization

Hypertension Research

Volumn 29, Issue 7, 2006, Pages 505-513

  Noda, Toshitaka ^a   Yaginuma, Toshio ^b   O'Rourke, Michael F ^c,d   Hosoda, Saichi ^e  

^a Noda Clinic   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ST VINCENT'S CLINIC   (Australia)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Peripheral resistance; Pressure wave augmentation; Vasodilation; Wave reflection

Indexed keywords

GLYCERYL TRINITRATE; NIFEDIPINE; NITROPRUSSIDE SODIUM;

ADULT; ANGINA PECTORIS; AORTA PRESSURE; ARTERIOLE; ARTERY DILATATION; ARTICLE; ASCENDING AORTA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART OUTPUT; HEART RIGHT VENTRICLE PRESSURE; HEART STROKE VOLUME; HEART WORK; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; PULMONARY ARTERY; SYSTEMIC CIRCULATION; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; VASODILATATION;

ADMINISTRATION, SUBLINGUAL; ADULT; ALGORITHMS; CALCIUM CHANNEL BLOCKERS; CARDIAC OUTPUT; CORONARY CIRCULATION; DATA INTERPRETATION, STATISTICAL; HEART CATHETERIZATION; HEMODYNAMIC PROCESSES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NIFEDIPINE; PULMONARY CIRCULATION; VASCULAR RESISTANCE; VASODILATION; VENTRICULAR FUNCTION, LEFT;

EID: 33748560107     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.505     Document Type: Article

References (39)

1. Polese A, Fiorentini C, Olivari MT, Guazzi MD: Clinical use of calcium antagonist agent (nifedipine) in acute pulmonary oedema Am J Med 1979; 66: 825-830.
2. Colucci W: Usefulness of calcium antagonists for congestive heart failure. Am J Cardiol 1987; 59: 52B-58B.
3. O'Rourke RA, Walsh RA: Experience with calcium antagonist drugs in congestive heart failure. Am J Cardiol 1987; 59: 64B-69B.
4. Morrow DA, Gersch BJ, Braunwald E: Chronic coronary artery disease, in Zipes DP, Libby P, Bonow RO, Braunwald E (eds): Heart Disease, 7th ed. Philadelphia, WB Saunders, 2005, pp 1281-1341.
5. Opie LH: Calcium channel antagonists, in Opie LH, Gersh BJ (eds): Drugs for the Heart, 5th ed. Philadelphia, WB Saunders, 2001.
6. Safar ME, O'Rourke MF (eds): Handbook of Hypertension, 23rd ed. Elsevier, Edinburgh, 2006, pp 503-516.
7. Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S: Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994; 331: 689-694.
8. Rich S, Kaufmann E, Levey PS: The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327: 76-81.
9. Zusman RM, Christensen DM, Federman EB, Ruddy TD, Miller DD, Boucher CA: Nifedipine but not propranolol improves left ventricular systolic and diastolic function in patients with hypertension. Am J Cardiol 1989; 64: 51F-61F.
10. Nichols WW, O'Rourke MF: McDonalds Blood Flow in Arteries, 5th ed. London, Arnold, 2005.
11. Chang KC, Hsieh KS, Kuo TS, Chen HI: Effects of nifedipine on systemic hydraulic vascular load in patients with hypertension. Cardiovasc Res 1990; 24: 719-726.
12. Ting CT, Chen JW, Chang MS, Yin FC: Arterial hemodynamics in human hypertension. Effects of the calcium channel antagonist nifedipine. Hypertension 1995; 25: 1326-1332.
13. Yaginuma T, Noda T, Tsuchiya M, et al: Interaction of left ventricular contraction and aortic input impedance in experimental and clinical studies. Jpn Circ J 1985; 49: 206-214.
14. Takazawa K: A clinical study of the second component of left ventricular systolic pressure. J Tokyo Med Coll 1987; 45: 256-270.
15. Murgo JP, Westerhof N, Giolma JP, Altobelli SA: Aortic input impedance in normal man: relationship to pressure waveforms. Circulation 1980; 62: 105-116.
16. O'Rourke MF, Taylor MG: Input impedance of the systemic circulation. Circ Res 1967; 20: 365-380.
17. Nichols WW, Conti CR, Walker We, Milnor WR: Input impedance of the systemic circulation in man. Circ Res 1977; 40: 451-458.
18. Gundel W, Cherry G, Rajagopalan B, Tan L-B, Lee G, Schultz D: Aortic input impedance in man: acute response to vasodilator drugs. Circulation 1981; 63: 1305-1314.
19. Merillon JP, Fontenier G, Lerallut JF, et al: Aortic input impedance in normal man and arterial hypertension: its modification during changes in aortic pressure. Cardiovasc Res 1982; 16: 646-656.
20. Merillon JP, Fontenier G, Leralluit JF, et al: Aortic input impedance in heart failure: comparison with normal subjects and its changes during vasodilator therapy. Eur Heart J 1984; 5: 447-455.
21. Laskey WK, Kussmaul WG, Martin JL, Kleaveland JP, Hirshfeld JW Jr, Shroff S: Characteristic of vascular hydraulic load in patients with heart failure. Circulation 1985; 72: 61-71.
22. Pepine CJ, Nichols WW, Curry RC, Conti CR: Aortic input impedance during nitroprusside infusion. J Clin Invest 1979; 64: 643-654.
23. Fitchett DH, Simkus GH, Beaudry JP, Marpole DGH: Reflected pressure waves in the ascending aorta: effects of glyceryl trinitrate. Cardiovasc Res 1988; 22: 494-500.
24. Yaginuma T, Avolio AP, O'Rourke MF, et al: Effects of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res 1986; 20: 153-160.
25. Ting CT, Brin KP, Lin SJ, et al: Arterial hemodynamics in human hypertension. J Clin Invest 1986; 78: 1462-1471.
26. Ting CT, Chou CY, Chang MS, Wang FSP, Chiang BN, Ying FCP: Arterial hemodynamics in human hypertension: effects of adrenergic blockade. Circulation 1991; 84: 1049-1057.
27. Milnor WR, Conti CR, Lewis KB, O'Rourke MF: Pulmonary arterial pulse wave velocity and impedance in man. Circ Res 1969; 25: 637-649.
28. Murgo JP, Westerhof N: Input impedance of the pulmonary arterial system in normal man: effects of respiration and comparison to systemic impedance. Circ Res 1984; 54: 666-673.
29. Yin FCP, Guzman PA, Brin KP, et al: Effect of nitroprusside on hydraulic vascular loads on the right and left ventricle of patients with heart failure. Circulation 1983; 67: 1330-1339.
30. Latham RD, Westerhof N, Sipkema P, Rubal B, Reuderink P: Regional wave travel and reflections along the human aorta: a study with six simultaneous micromanometric pressures. Circulation 1985; 72: 1257-1269.
31. Nichols WW, O'Rourke MF, Avolio AP, et al: Effects of age on ventricular-vascular coupling. Am J Cardiol 1985; 55: 1179-1184.
32. Laskey WR, Kussmaul WG: Arterial wave reflections in heart failure. Circulation 1987; 75: 711-722.
33. Kelly RP, Gibbs H, O'Rourke MF, et al: Nitroglycerin has more favorable effects on the left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990; 11: 138-144.
34. O'Rourke MF: Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990; 15: 339-347.
35. Safar ME, London GM: Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. J Hypertens 2000; 18: 1527-1535.
36. Pepine CJ, Nichols WW, Conti CR: Aortic input impedance in heart failure. Circulation 1978; 58: 460-465.
37. Safar ME: Epidemiological findings imply that goals for drug treatment of hypertension need to be revised. Circulation 2001; 103: 1188-1190.
38. Fujita M, Takazawa K, Tanaka N, Ibukiyama C: Effects of nicorandil on aortic input impedance - a comparative study with nitroglycerine. Jpn Circ J 1999; 63: 111-116.
39. Yui Y, Sumiyoshi T, Kodama. K, et al: Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial. Hypertens Res 2004; 27: 181-191.